Table 2.

Prevalence of Metabolic Syndrome Risk Factors and Diabetes Among 3,403 Participants in the Coronary Artery Risk Development in Young Adults (CARDIA) Study at the Baseline exam (1985 – 1986).

	Race-Sex Groups
	White Men		White Women		Black Men		Black Women
	Baseline	Year 10	Baseline	Year 10	Baseline	Year 10	Baseline	Year 10
Total Baseline N = 3,404; Year-10 N = 2,532	855 %	681 %	964 %	757 %	675 %	435 %	909 %	659 %
HOMA-IR top quartile	23.2	22.6	14.6	14.3	29.0	30.8	34.4	36.9
HOMA-IR top decile	6.6	8.5	5.5	4.6	11.7	13.6	16.9	15.2
Diabetic (Glucose ≥ 126mg/dL) *	0.7	2.1	0.9	5.4	0.9	2.1	1.8	8.8
Hypertensive (SBP or DBP ≥ 140/90 mmHg) *	3.7	4.0	1.7	2.1	5.3	12.6	4.7	12.0
Elevated BP (SBP or DBP ≥ 130/85 mmHg) *	12.4	12.2	3.2	4.2	14.2	21.8	6.7	18.4
Obese (BMI ≥ 30)	6.2	16.3	7.4	17.0	9.3	24.6	19.4	41.0
Obese waist (≥ 102 cm men; > 88cm women)	3.0	12.2	6.2	18.8	4.7	13.8	13.3	40.1
High triglycerides (≥ 150 mg/dL)	10.1	22.2	3.7	8.5	4.2	10.8	1.7	4.9
High cholesterol (≥ 200 mg/dL)	21.6	27.8	20.8	22.5	23.9	25.8	25.5	18.4
High LDL-C (≥ 160 mg/dL)	7.5	9.4	3.8	4.4	6.7	8.1	7.6	4.7
Low HDL-C (< 40 mg/dL men; < 50mg/dl women)	22.1	40.1	31.6	36.6	12.4	25.5	32.0	41.0
High uric acid (> 7 men; > 6 women)	23.0	11.8	7.5	2.5	20.4	16.1	7.6	4.9
Dyslipidemia†	39.4	57.0	46.9	50.7	33.9	46.4	50.4	54.0

Abbreviations: HOMA-IR, Homeostasis model assessment insulin resistance [(fasting glucose × fasting insulin)/22.5]; SBP, systolic blood pressure; DBP, diastolic blood pressure; BP, blood pressure; BMI, body mass index; LDL-C, low density lipoprotein cholesterol; HDL-C, high density lipoprotein cholesterol

^*Also includes individuals with normal levels but reported taking medication for the condition

^†At risk level present in triglycerides, total cholesterol, low density lipoprotein cholesterol, or high density lipoprotein cholesterol